<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>COVID的大型研究发现雷米希韦不起作用-FDA无论如何都会批准</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">COVID的大型研究发现雷米希韦不起作用-FDA无论如何都会批准</h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2020-10-24 07:53:09</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2020/10/3eed5481a6fa56c1791e9005aef9dca5.jpg"><img src="http://img2.diglog.com/img/2020/10/3eed5481a6fa56c1791e9005aef9dca5.jpg" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>The US Food and Drug Administration on Thursday  issued a full approval of the antiviral drug remdesivir for treating COVID-19—just days after  a massive global study concluded that the drug provides no benefit.</p><p>周四，美国食品和药物管理局(FDA)全面批准了用于治疗新冠肺炎的抗病毒药物redesivir-就在几天前，一项大规模的全球研究得出结论，该药物没有任何好处。</p><p> “The FDA is committed to expediting the development and availability of COVID-19 treatments during this unprecedented public health emergency,” FDA Commissioner Stephen Hahn said in a statement. “Today’s approval is supported by data from multiple clinical trials that the agency has rigorously assessed and represents an important scientific milestone in the COVID-19 pandemic.”</p><p>食品和药物管理局局长斯蒂芬·哈恩在一份声明中说：“在这场史无前例的突发公共卫生事件中，食品和药物管理局致力于加快新冠肺炎治疗药物的开发和供应。”“今天的批准得到了该机构严格评估的多项临床试验数据的支持，这些数据代表着新冠肺炎大流行的一个重要科学里程碑。”</p><p>  The FDA made its decision based on three clinical trials on remdesivir, a repurposed experimental antiviral drug brand-named Veklury. One was  a randomized, double-blind, placebo-controlled trial run by the National Institute of Allergy and Infectious Diseases. It included 1,062 hospitalized COVID-19 patients, 541 of which received remdesivir. The trial concluded that remdesivir shortened the median recovery time from the infection from 15 days to 10 days. The researchers running the trial defined “recovery” of a patient as either a patient being discharged from the hospital—regardless if the patient still had lingering symptoms that limited activities or required supplemental oxygen to be taken at home—or a patient remaining in the hospital but no longer requiring medical care, such as if they were kept in the hospital for infection-control reasons.</p><p>FDA是基于对redesivir的三项临床试验做出这一决定的，redesivir是一种改用的实验性抗病毒药物，名为Veklury。一项是由国家过敏和传染病研究所进行的随机、双盲、安慰剂对照试验。包括1,062名住院的新冠肺炎患者，其中541人接受了药物治疗。试验的结论是，雷米德韦将感染的中位恢复时间从15天缩短到10天。运行这项试验的研究人员将患者的“康复”定义为要么患者出院-无论患者是否仍有限制活动或需要在家中补充氧气的挥之不去的症状-要么患者仍在医院但不再需要医疗护理，比如如果他们因为感染控制的原因被留在医院。</p><p> The other two trials the FDA considered were conducted by Gilead, the company that makes remdesivir.  One trial looked at about 600 people with moderate cases COVID-19. Patients were split into three groups, each about 200 people—a group that got a 10-day course of remdesivir, a group that got a 5-day course, and a control group that got standard treatments. At day 11 of treatments, the group that had the 5-day course of remdesivir showed a statistically significant improvement in symptom scores compared with the control group. The group that got a 10-day course of remdesivir did not have a statistically significant improvement over the control group, though.</p><p>FDA考虑的另外两项试验是由制造瑞德韦尔的吉利德公司进行的。其中一项审判调查了约600名中度病例的新冠肺炎。患者被分成三组，每组约200人-一组接受10天的瑞希韦疗程，一组接受5天的疗程，以及一组接受标准治疗。在治疗的第11天，与对照组相比，接受5天雷米德韦疗程的组的症状评分有统计学上的显著改善。然而，接受了10天疗程的瑞希韦的那一组与对照组相比没有统计上的显著改善。</p><p> The other Gilead trial looked at 400 patients with severe COVID-19. They were split about evenly into just two groups—a group that got a 5-day course of remdesivir and a group that got a 10-day course. There were no statistically significant differences in recovery or deaths between the two groups.</p><p>吉利德的另一项试验观察了400名新冠肺炎病情严重的患者。他们被平均分成两组-一组接受了5天的redesivir疗程，另一组接受了10天的疗程。两组在康复或死亡方面没有统计学上的显著差异。</p><p>  “The [FDA] approval of Veklury marks an important milestone in efforts to help address the pandemic by offering an effective treatment that helps patients recover faster and, in turn, helps preserve scarce healthcare resources,” Barry Zingman said in  a press statement released by Gilead. Zingman is a professor at Albert Einstein College of Medicine and one of the researchers who conducted the NIAID trial of remdesivir.</p><p>Barry Zingman在吉利德发布的一份新闻声明中说：“(FDA)批准Veklury标志着通过提供一种有效的治疗方法，帮助患者更快康复，进而帮助保存稀缺的医疗资源，从而帮助应对大流行的努力具有重要的里程碑意义。”Zingman是阿尔伯特·爱因斯坦医学院的教授，也是进行NIAID雷米德韦试验的研究人员之一。</p><p> But the FDA’s approval of remdesivir falls on the heels of data form the fourth and largest trial of the drug, and that trial showed no benefit. The data comes from the World Health Organization’s massive  Solidarity trial, which set up an international network of trials enrolling nearly 12,000 patients at 500 sites in over 30 countries, testing multiple repurposed therapeutics. Remdesivir was initially developed over a decade ago as a potential treatment for hepatitis C and RSV (respiratory syncytial virus). It has also been tested against Ebola but was beat out by other treatments.</p><p>但是FDA对瑞德韦尔的批准紧跟在该药物第四次也是最大规模试验的数据之后，而那次试验并没有显示出任何益处。这些数据来自世界卫生组织(World Health Organization)的大规模团结试验，该试验建立了一个国际试验网络，在30多个国家的500个地点招募了近1.2万名患者，测试多种重新调整用途的疗法。Remdevir最初是在十多年前开发的，作为治疗丙型肝炎和呼吸道合胞病毒(RSV)的潜在药物。它还进行了对抗埃博拉病毒的测试，但被其他治疗方法击败。</p><p> According to preliminary results from the Solidarity trial—reported online last week ahead of its planned publication in the New England Journal of Medicine—remdesivir was given to 2,743 patients, and their outcomes were compared with those of 2,708 patients given standard treatments. Between the two groups, WHO found that remdesivir did not reduce mortality. It also did not change how many patients progressed to needing mechanical ventilation, nor did it change the proportion of patients discharged after seven days of hospitalization.</p><p>根据团结试验的初步结果-上周在线报道了该试验的计划发表在《新英格兰医学杂志》(The New England Journal Of Medicine)上-给了2743名患者雷米德韦尔，并将他们的结果与接受标准治疗的2708名患者的结果进行了比较。世卫组织发现，在这两组人中，雷米西韦并不能降低死亡率。它也没有改变有多少患者进展到需要机械通气，也没有改变患者在住院7天后出院的比例。</p><p> When the Solidarity trial data was first released, Gilead  blasted the results, saying, “The emerging data appear inconsistent with more robust evidence from multiple randomized, controlled studies validating the clinical benefit of [remdesivir].”</p><p>当团结试验的数据首次公布时，吉列德猛烈抨击了结果，说：“新出现的数据似乎与多个随机对照研究验证[redesivir]临床益处的更有力的证据不一致。”</p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://arstechnica.com/science/2020/10/fda-approves-remdesivir-for-covid-19-but-global-study-finds-it-doesnt-work/">https://arstechnica.com/science/2020/10/fda-approves-remdesivir-for-covid-19-but-global-study-finds-it-doesnt-work/</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/发现/">#发现</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/covid/">#covid</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/患者/">#患者</a></button></div></div><div class="shadow p-3 mb-5 bg-white rounded clearfix"><div class="container"><div class="row"><div class="col-sm"><div><a target="_blank" href="/story/1029201.html"><img src="http://img2.diglog.com/img/2020/10/thumb_3e29933a0f082880df6ba466a4241b4e.jpg" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1029201.html">罗宾汉内部调查发现黑客攻击了近2000个账户</a></div><span class="my_story_list_date">2020-10-16 19:48</span></div><div class="col-sm"><div><a target="_blank" href="/story/1028219.html"><img src="http://img2.diglog.com/img/2020/10/thumb_251a6a4c7f03216cb4772e8f34d0c290.jpeg" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1028219.html">研究发现，谷歌和苹果的联系人追踪API在公共交通上不起作用</a></div><span class="my_story_list_date">2020-10-12 7:23</span></div><div class="col-sm"><div><a target="_blank" href="/story/1028199.html"><img src="http://img2.diglog.com/img/2020/10/thumb_7d0680142eabb3a09328b33e41ec55d0.jpg" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1028199.html">据说圣马修岛是阿拉斯加最偏远的地方</a></div><span class="my_story_list_date">2020-10-12 7:7</span></div><div class="col-sm"><div><a target="_blank" href="/story/1028015.html"><img src="http://img2.diglog.com/img/2020/10/thumb_88724691d6bef510987abc4fc6bb01ba.jpg" class="img-fluid" onerror="this.style.display='none'"></a></div><div class="item_title"><a target="_blank" href="/story/1028015.html">科学家发现音速上限</a></div><span class="my_story_list_date">2020-10-11 16:28</span></div></div></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/美国/">#美国</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/谷歌/">#谷歌</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/linux/">#linux</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/程序/">#程序</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>